(Q37776811)

23 August 2017

1 reference

title

Physiologic insulin delivery with insulin feedback: a control systems perspective (English)

1 reference

23 August 2017

Physiologic insulin delivery with insulin feedback: A control systems perspective (English)

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

14 June 2024

1 reference

Feedback, Physiological

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20674062

14 June 2024

author name string

Cesar C. Palerm

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20674062

14 June 2024

language of work or name

1 reference

2 August 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0169260710001501?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

https://api.elsevier.com/content/article/PII:S0169260710001501?httpAccept=text/plain

14 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Computer Methods and Programs in Biomedicine

14 June 2024

published in

1 reference

23 August 2017

102

1 reference

23 August 2017

2

1 reference

23 August 2017

130-137

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

23 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas

14 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Continuous glucose monitoring and closed-loop systems

14 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Artificial pancreas: an emerging approach to treat Type 1 diabetes

14 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Closed-loop insulin delivery-the path to physiological glucose control

14 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience

14 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial

14 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

A bihormonal closed-loop artificial pancreas for type 1 diabetes

14 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes

14 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

A model for technology assessment as applied to closed loop infusion systems. Technology Assessment Task Force of the Society of Critical Care Medicine

14 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Closed-loop insulin delivery - what lies between where we are and where we are going?

14 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Evaluation of the effect of gain on the meal response of an automated closed-loop insulin delivery system

14 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Modeling beta-cell insulin secretion--implications for closed-loop glucose homeostasis

14 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Feasibility of automating insulin delivery for the treatment of type 1 diabetes

14 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas

14 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Evaluation of insulin sensitivity and beta-cell function indexes obtained from minimal model analysis of a meal tolerance test

14 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Standards of medical care in diabetes--2009.

14 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Glycemic variability: should we and can we prevent it?

14 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

The volume and energy content of meals as determinants of gastric emptying

14 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Antecedent caloric intake and glucose excursion following a subsequent meal in Type 1 diabetes

14 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system.

14 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas

14 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Sensitivity of insulin secretion to feedback inhibition by hyperinsulinaemia.

14 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Feedback inhibition of insulin on insulin secretion in isolated pancreatic islets

14 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects

14 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Pharmacokinetic model selection for target controlled infusions of propofol. Assessment of three parameter sets.

14 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes.

14 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes.

14 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

The role of amylin in the physiology of glycemic control

14 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus

14 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes

14 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

The role of prandial pramlintide in the treatment of adolescents with type 1 diabetes

14 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Effect of adjunctive pramlintide treatment on treatment satisfaction in patients with type 1 diabetes.

14 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

Physiologic insulin delivery with insulin feedback: A control systems perspective

14 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.CMPB.2010.06.007

14 June 2024

Identifiers

1 reference

23 August 2017

journals/cmpb/Palerm11

1 reference

DBLP Dataset 2021-01-02

28 January 2021

1 reference